Intestinal microbiota and antibiotic-associated acute gastrointestinal injury in sepsis mice

Ci Han1, Nana Guo2, Yue Bu2

  • 1Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin 150001, Heilongjiang, China.

Aging
|April 5, 2021
PubMed
Abstract

Insights

Antibiotics alter gut microbiota and metabolites in sepsis mice, impacting intestinal motility. Targeting Desulfovibrio and using benzoic acid may reduce acute gastrointestinal injury.

Area of Science:

  • Microbiology
  • Metabolomics
  • Gastroenterology

Background:

  • Sepsis can cause acute gastrointestinal injury.
  • Antibiotic use impacts intestinal microbiota and metabolites.

Purpose of the Study:

  • Investigate changes in intestinal microbiota and metabolites in sepsis mice with acute gastrointestinal injury before and after antibiotic treatment.
  • Explore the effects of these changes on the body.

Main Methods:

  • Utilized 16S rRNA sequencing and untargeted metabolomics on mouse fecal samples.
  • Assessed intestinal motility in sepsis mice after 3-day treatment.
  • Employed a three-group experimental design with SPF-grade C57BL/6J male mice.

Main Results:

  • Antibiotic administration altered intestinal microbiota composition and metabolite profiles.
  • Significant differences in bacterial species, including Desulfovibrio, were observed.
  • Intestinal microbiota composition correlated with changes in intestinal motility; benzoic acid and 4-hydroxybenzoic acid were associated with Desulfovibrio.

Conclusions:

  • Antibiotic-induced changes in gut microbiota and metabolites may influence acute gastrointestinal injury severity in sepsis.
  • Inhibiting Desulfovibrio and utilizing benzoic acid/4-hydroxybenzoic acid as biomarkers could mitigate inflammation in acute gastrointestinal injury.